Related Experiment Video
Updated: Mar 15, 2026
12:09
Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
10.7K
TRPV1: A Target for Rational Drug Design
Vincenzo Carnevale1, Tibor Rohacs2
1Institute for Computational Molecular Science, Temple University, Philadelphia, PA 19122, USA. vincenzo.carnevale@temple.edu.
Pharmaceuticals (Basel, Switzerland)
|August 27, 2016
Summary
Transient Receptor Potential Vanilloid 1 (TRPV1) channels are key targets for pain relief. This review explores TRPV1 antagonists and agonists, discussing strategies for developing improved drugs using new structural data.
Area of Science:
- Molecular biology
- Neuroscience
- Pharmacology
Background:
- Transient Receptor Potential Vanilloid 1 (TRPV1) is a Ca(2+) permeable cation channel activated by heat and chemicals like capsaicin.
- TRPV1 plays a significant role in pain signaling pathways.
- Existing TRPV1-targeting drugs have not reached routine clinical use.
Purpose of the Study:
- To review the therapeutic potential of TRPV1 antagonists and agonists for pain management.
- To discuss strategies for developing novel and improved TRPV1-targeting drugs.
- To leverage recent high-resolution structural data of TRPV1 for drug design.
Main Methods:
- Literature review of existing research on TRPV1.
- Analysis of high-resolution structural data of the TRPV1 channel.
- Discussion of drug development strategies for TRPV1 modulators.
Main Results:
- Numerous compounds targeting TRPV1 have been developed, but none are in widespread clinical use.
- High-resolution structures provide new insights into TRPV1 channel function and drug binding.
- Both antagonists and agonists show potential for therapeutic applications beyond pain.
Conclusions:
- TRPV1 remains a promising target for novel therapeutics.
- Utilizing structural biology is crucial for designing more effective and selective TRPV1 drugs.
- Further research is needed to overcome challenges in clinical translation for TRPV1-based therapies.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
01:29Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
01:30Quantitative Aspects of Drug-Receptor Interaction
2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
01:28Drug-Receptor Interaction: Antagonist
5.4K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
5.4K
01:26Drug Discovery: Overview
12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
01:24Principles of Drug Action
9.3K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.3K